ArticleVeterinary world2025
Development of high-titer polyclonal antisera targeting a local bovine viral diarrhea virus-1a strain: A preliminary study from Indonesia.
Article in Veterinary world, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Bovine viral diarrhea virus (BVDV) is an economically significant pathogen of cattle, causing reproductive disorders, immunosuppression, and production losses worldwide. In Indonesia, BVDV-1a is among the most prevalent subgenotypes; however, field diagnosis still relies heavily on imported kits developed using non-local strains, which can lead to potential gaps in sensitivity and specificity. Locally tailored immunological reagents could enhance diagnostic accuracy and support future control strategies. This study aimed to produce and characterize polyclonal antisera against a local BVDV-1a isolate from Indonesia. Materials and Methods: Four New Zealand white rabbits were immunized with inactivated BVDV-1a antigen propagated in Madin-Darby bovine kidney (MDBK) cells. Booster immunizations were administered on days 14 and 28. Ten days after the final booster, sera were collected, pooled, and purified using ammonium sulfate precipitation and dialysis. Purified antisera were characterized by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Antibody titers were assessed using indirect enzyme-linked immunosorbent assay (ELISA), and specificity was validated by immunoperoxidase monolayer assay (IPMA) in infected MDBK cells. Results: The purification process yielded polyclonal antisera with a protein concentration of 40.33 mg/mL. SDS-PAGE revealed characteristic bands at approximately 53, 75, and 100 kDa, consistent with immunoglobulin components. Indirect ELISA showed strong antibody titers, with positive reactivity sustained up to 1:100. IPMA confirmed specific recognition of BVDV antigens, as infected MDBK cells exhibited distinct cytoplasmic staining, whereas uninfected controls remained negative. Conclusion: This preliminary study successfully generated high-titer polyclonal antisera against a local Indonesian BVDV-1a strain. The antibodies demonstrated robust reactivity and specificity, highlighting their potential utility as foundational reagents for developing regionally relevant diagnostic assays. While limited by a small sample size and pooled sera, these findings represent an important first step toward establishing locally adapted immunodiagnostic resources for BVDV. The development of local diagnostic tools not only strengthens veterinary disease surveillance but also safeguards livestock-dependent livelihoods, enhances food security, and reduces reliance on imported kits. Improved BVDV control in cattle contributes to One Health by minimizing economic losses, ensuring the safety of animal-derived food products, and reducing the risk of viral persistence in mixed livestock populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.